Skip to main content
logo
Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
535.27
+19.93 (3.87%)
At close: Aug 11, 2026, 4:00 PM EDT
539.00
+3.73 (0.70%)
Pre-market: Aug 12, 2026, 9:15 AM EDT

Madrigal Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,284958.4180.13---
Revenue Growth
149.04%432.05%----
Gross Profit
1,175902.26173.9---
Operating Income
-322.62-300.1-497.88-380.5-293.57-242.48
Net Income
-325.1-288.28-465.89-373.63-295.35-241.85
Earnings Per Share
-11.82-12.85-21.90-19.99-17.23-14.63
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
838.75983.56926.25634.13358.77270.35
Total Debt
347.75347.63119.57117.1949.890.8
Net Cash (Debt)
491635.93806.68516.94308.88269.55
Net Cash Growth
-27.05%-21.17%56.05%67.36%14.59%-4.88%
Net Cash Per Share
17.9328.3537.9227.6618.0216.30

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-197.72-189.55-455.57-324.23-224.86-183.92
Capital Expenditures
-8.57-0.47-1.46-1.48-0.22-0.21
Free Cash Flow
-206.29-190.02-457.03-325.71-225.07-184.13
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
91.48%94.14%96.54%---
Operating Margin
-25.13%-31.31%-276.39%---
Pretax Margin
-25.10%-30.08%-258.64%---
Profit Margin
-25.32%-30.08%-258.64%---
FCF Margin
-16.07%-19.83%-253.72%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-191.16----
PS Ratio
9.6315.3237.69---